Original Research
Published on 10 Feb 2023
Pharmacovigilance on cannabidiol as an antiepileptic agent
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1091978
- 5,178 views
- 22 citations
21 articles related to "Eudravigilance"
Articles
Original Research
Published on 09 Jan 2026
Gender and age variations in neuropsychiatric adverse events of cetirizine and levocetirizine: a disproportionality analysis of ICSRs from FAERS and EudraVigilance data
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1737359
- 1,213 views
Original Research
Published on 06 Apr 2023
Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1130636
- 5,060 views
- 10 citations
Original Research
Published on 02 Dec 2020
We Really Need Clear Guidelines and Recommendations for Safer and Proper Use of Aripiprazole and Risperidone in a Pediatric Population: Real-World Analysis of EudraVigilance Database
in Child and Adolescent Psychiatry
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.550201
- 11,400 views
- 17 citations
Mini Review
Published on 29 Sep 2022
Thrombotic events with or without thrombocytopenia in recipients of adenovirus-based COVID-19 vaccines
in Thrombosis and Haemostasis
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.967926
- 4,549 views
- 11 citations
Original Research
Published on 06 Sep 2022
Analysis of pharmacovigilance databases for spontaneous reports of adverse drug reactions related to substandard and falsified medical products: A descriptive study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.964399
- 12,144 views
- 30 citations
Original Research
Published on 29 Mar 2022
Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.844122
- 5,121 views
- 9 citations
Original Research
Published on 24 Jul 2024
Seriousness and outcomes of reported adverse drug reactions in old and new antiseizure medications: a pharmacovigilance study using EudraVigilance database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1411134
- 3,475 views
- 3 citations
Original Research
Published on 13 Sep 2022
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.956825
- 11,604 views
- 20 citations
Original Research
Published on 22 Jan 2026
Differential musculoskeletal outcome reporting in patients receiving bempedoic acid or atorvastatin: a disproportionality analysis using the EudraVigilance database
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1736657
- 983 views
Original Research
Published on 29 Jan 2026
Drug-induced male infertility: a real-world study using FAERS and EudraVigilance databases
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1765071
- 1,068 views
Original Research
Published on 09 Jan 2026
Hepatobiliary adverse drug reactions during treatment with olaparib: an analysis of data from the EudraVigilance reporting system
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1736759
- 946 views
- 1 citation
Original Research
Published on 14 Jan 2025
DNA methylation inhibitors adverse reaction characteristic analysis: an analysis based on the European spontaneous adverse event reporting system
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1527903
- 1,830 views
Original Research
Published on 19 Feb 2025
Network analysis of adverse event patterns following immunization with mRNA COVID-19 vaccines: real-world data from the European pharmacovigilance database EudraVigilance
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2025.1501921
- 32,133 views
- 5 citations
Original Research
Published on 15 Jun 2022
Myelodysplastic Syndrome/Acute Myeloid Leukemia Following the Use of Poly-ADP Ribose Polymerase (PARP) Inhibitors: A Real-World Analysis of Postmarketing Surveillance Data
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2022.912256
- 15,710 views
- 31 citations
Original Research
Published on 09 May 2025
Musculoskeletal adverse events in dogs receiving bedinvetmab (Librela)
in Anesthesiology and Animal Pain Management
Frontiers in Veterinary Science
doi 10.3389/fvets.2025.1581490
- 320,809 views
- 11 citations